Explore Our Biomarker Menu

Biomarker:

p62 (SQSTM1) (total)

Biological or Clinical Significance:

The p62/Sequestosome 1 (p62, SQSTM1) protein is a scaffold protein that binds polyubiquitin chains and forms a cytoplasmic “sequestosome” where ubiquitinated, mis-fold, or non-functional proteins are stored for autophagic degradation. Tumor cells often utilize autophagy for survival in low nutrient and hypoxic conditions or in response to cancer treatments. Inhibition of p62 action may enhance chemotherapies by disrupting the pro-survival signaling cascades that work to maintain cell integrity and limit apoptosis. P62 functions in concert with tumor necrosis factor receptor associated factor 6 to mediate activation of nuclear factor kappa-B signaling pathway in response to upstream signals involving atypical protein kinase C. Over expression or dysregulation of p62 interactions can result in large cytoplasmic aggregates including those found in aggregation diseases affecting the brain and liver.

References:

Analyte:

p62 (SQSTM1) (total)

Matrix:

Status:

Experienced Running

Sensitivity-LLOQ:

Sensitivity-ULOQ:

platform

MSD-ECL

Required Sample Volume

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.


    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.